Omni-Tract Surgical (www.omni-tract.com) is a St. Paul, Minnesota-based designer and manufacturer of highly engineered table-mounted surgical retractor systems. Since 1971, the company has pioneered the research, design and development of retractor systems that help surgeons around the world solve the most complex surgical exposure challenges. The company’s retractor systems are utilized in a variety of surgical procedures, including general, vascular, bariatric/transplant, orthopedic and gynecologic, among others. Omni-Tract Surgical’s comprehensive line of table-mounted retractor systems are marketed internationally under the Omni-Flex™, FastSystem®, and Speed-Tract™ brands.
Omni-Tract Surgical participates in a niche segment of the $40+ billion global surgical device and instrument market. The company has established itself as a global leader within its niche, with leading market shares both domestically and abroad. The company’s primary competitor is Codman & Shurtleff, Inc. (a Johnson & Johnson company), which markets the Bookwalter® line of surgical retractor systems.
Prestwick Partners initiated this transaction and acted as the exclusive financial advisor to Omni-Tract Surgical and its shareholders. Prestwick Partners designed an M&A process, prepared marketing materials, evaluated acquisition proposals and negotiated the transaction with Integra LifeSciences Holdings Corp. Our process included both domestic and international strategic acquirers as well as private equity groups.